These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3098311)

  • 21. Effect of chronic lithium treatment on 5-hydroxytryptamine autoreceptors and release of 5-[3H]hydroxytryptamine from rat brain cortical, hippocampal, and hypothalamic slices.
    Friedman E; Wang HY
    J Neurochem; 1988 Jan; 50(1):195-201. PubMed ID: 2826685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin-1C sites in the choroid plexus are not linked in a stimulatory or inhibitory way to adenylate cyclase.
    Palacios JM; Markstein R; Pazos A
    Brain Res; 1986 Aug; 380(1):151-4. PubMed ID: 3019464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin- and dopamine-sensitive adenylate cyclase in molluscan nervous system. Biochemical and electrophysiological analysis of the pharmacological properties and the GTP-dependence.
    Deterre P; Paupardin-Tritsch D; Bockaert J
    Brain Res; 1986 Nov; 387(2):101-9. PubMed ID: 3791004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic effects of imipramine and lithium on 5-HT receptor subtypes in rat frontal cortex, hippocampus and choroid plexus: quantitative receptor autoradiographic analysis.
    Mizuta T; Segawa T
    Jpn J Pharmacol; 1989 Jul; 50(3):315-26. PubMed ID: 2761132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postnatal development of 5-HT1 receptors: [3H]5-HT binding sites and 5-HT induced adenylate cyclase activations in rat brain cortex.
    Zifa E; Hernandez J; Fayolle C; Fillion G
    Brain Res Dev Brain Res; 1988 Nov; 44(1):133-40. PubMed ID: 3233729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
    Schoeffter P; Hoyer D
    Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin-sensitive adenylate cyclase and [3H]serotonin binding sites in the CNS of the rat--I.
    Nelson DL; Herbet A; Enjalbert A; Bockaert J; Hamon M
    Biochem Pharmacol; 1980 Sep; 29(18):2445-53. PubMed ID: 7426051
    [No Abstract]   [Full Text] [Related]  

  • 28. Pertussis toxin attenuates 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat hippocampal membranes.
    Okada F; Tokumitsu Y; Nomura Y
    J Neurochem; 1989 May; 52(5):1566-9. PubMed ID: 2523468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of Ni protein in the functional coupling of the atrial natriuretic factor (ANF) receptor to adenylate cyclase in rat lung plasma membranes.
    Resink TJ; Panchenko MP; Tkachuk VA; Bühler FR
    Eur J Biochem; 1988 Jun; 174(3):531-5. PubMed ID: 2839333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortical 5-HT(1A) receptor downregulation by antidepressants in rat brain.
    Srinivas BN; Subhash MN; Vinod KY
    Neurochem Int; 2001 Jun; 38(7):573-9. PubMed ID: 11290382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of an adenylate cyclase-linked serotonin (5-HT1) receptor in a neuroblastoma X brain explant hybrid cell line (NCB-20).
    Berry-Kravis E; Dawson G
    J Neurochem; 1983 Apr; 40(4):977-85. PubMed ID: 6834055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
    Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS
    Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of galanin and 5-HT1A receptor coupling to adenylyl cyclase in discrete regions of the rat brain.
    Billecocq A; Hedlund PB; Bolaños-Jiménez F; Fillion G
    Eur J Pharmacol; 1994 Oct; 269(2):209-17. PubMed ID: 7531647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium, an inhibitor of cAMP-induced inositol 1,4,5-trisphosphate accumulation in Dictyostelium discoideum, inhibits activation of guanine-nucleotide-binding regulatory proteins, reduces activation of adenylylcyclase, but potentiates activation of guanylyl cyclase by cAMP.
    Peters DJ; Snaar-Jagalska BE; Van Haastert PJ; Schaap P
    Eur J Biochem; 1992 Oct; 209(1):299-304. PubMed ID: 1356770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term lithium treatment causes serotonin receptor down-regulation via serotonergic presynapses in rat brain.
    Hotta I; Yamawaki S; Segawa T
    Neuropsychobiology; 1986; 16(1):19-26. PubMed ID: 3494960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
    Bouhelal R; Smounya L; Bockaert J
    Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coupling of an endogenous 5-HT1B-like receptor to increases in intracellular calcium through a pertussis toxin-sensitive mechanism in CHO-K1 cells.
    Dickenson JM; Hill SJ
    Br J Pharmacol; 1995 Dec; 116(7):2889-96. PubMed ID: 8680721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of Li inhibition of vasopressin-sensitive adenylate cyclase in cultured renal epithelial cells.
    Goldberg H; Clayman P; Skorecki K
    Am J Physiol; 1988 Nov; 255(5 Pt 2):F995-1002. PubMed ID: 2461098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
    Fischette CT; Nock B; Renner K
    Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus.
    Markstein R; Hoyer D; Engel G
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):335-41. PubMed ID: 2945992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.